To investigate the medication adherence of elderly hypertensive patients in community during the COVID-19 period and analyze its influencing factors. 392 elderly patients with hypertension were selected from two communities in Chengdu, Sichuan Province, and were investigated by demographic characters, circumstances in COVID-19 period, Morisky Medication Adherence Scale. chi-square test and binary logistic regression analysis were performed by SPSS 25.0 software. The medication adherence prevalence of elderly hypertensive patients from two communities in Chengdu was 43.37%. Binary logistic regression analysis showed that marital status, antihypertensive drug use during COVID-19 vaccination, antihypertensive drug use during COVID-19 treatment and emotional situation during the COVID-19 period were independent influencing factors of medication adherence of elderly hypertensive patients. During the COVID-19 period medication adherence among elderly hypertensive patients from two communities in Chengdu was poor.

Li Xiangxi, Chen Jiali, Wu Yan, Yu Zhongjie, Shuai Xiaolong. Medication Adherence and Influencing Factors of Elderly Hypertensive Patients during the COVID-19 Period: A Cross-Sectional Study in Chengdu, China. International Journal of Frontiers in Medicine (2023), Vol. 5, Issue 11: 55-62. https://doi.org/10.25236/IJFM.2023.051109.

[1] Hypertension. World Health Organization. https://www.who.int/news-room/fact-sheets/detail/hypertension. Accessed 2023-07-23.

[2] Organization WH. Global report on hypertension: The race against a silent killer. https://www.who.int/publications/i/item/9789240081062. Accessed 2023-07-23.

[3] Souza AC, Borges JW, Moreira TM. Quality of life and treatment adherence in hypertensive patients: systematic review with meta-analysis. Rev Saude Publica. 2016;50:71.

[4] Choudhry NK, Kronish IM, Vongpatanasin W, et al. Medication Adherence and Blood Pressure Control: A Scientific Statement From the American Heart Association. Hypertension. 2022;79(1):e1-e14.

[5] Foster M, Etchin A, Pope C, Hartmann CW, Emidio O, Bosworth HB. The Impact of COVID-19 on Hypertension and Hypertension Medication Adherence Among Underrepresented Racial and Ethnic Groups: A Scoping Review. Curr Hypertens Rep. 2023.

[6] Gómez-Escalonilla Lorenzo S, Martínez I, Notario Pacheco B. Influence of COVID-19 on treatment adherence and psychological well-being in a sample of hypertensive patients: a cross-sectional study. BMC Psychiatry. 2023;23(1):121.

[7] WHO downgrades COVID-19 global threat level. China Daily. https://www.chinadaily.com.cn/a/202305/06/WS6455206ca310b6054fad1547.html. Updated 2023-05-06. Accessed 2023-07-21.

[8] Müller-Wieland D, Marx N, Dreher M, Fritzen K, Schnell O. COVID-19 and Cardiovascular Comorbidities. Exp Clin Endocrinol Diabetes. 2022;130(3):178-189.

[9] Shahid Z, Kalayanamitra R, McClafferty B, et al. COVID-19 and Older Adults: What We Know. J Am Geriatr Soc. 2020;68(5):926-929.

[10] Crowley SD, Rudemiller NP. Immunologic Effects of the Renin-Angiotensin System. J Am Soc Nephrol. 2017;28(5):1350-1361.

[11] Ran J, Song Y, Zhuang Z, et al. Blood pressure control and adverse outcomes of COVID-19 infection in patients with concomitant hypertension in Wuhan, China. Hypertens Res. 2020;43(11):1267-1276.

[12] Burnier M, Polychronopoulou E, Wuerzner G. Hypertension and Drug Adherence in the Elderly. Front Cardiovasc Med. 2020;7:49.

[13] Kang CD, Tsang PP, Li WT, et al. Determinants of medication adherence and blood pressure control among hypertensive patients in Hong Kong: a cross-sectional study. Int J Cardiol. 2015;182:250-257.

[14] Rolnick SJ, Pawloski PA, Hedblom BD, Asche SE, Bruzek RJ. Patient characteristics associated with medication adherence. Clin Med Res. 2013;11(2):54-65.

[15] Alcántara C, Edmondson D, Moise N, Oyola D, Hiti D, Kronish IM. Anxiety sensitivity and medication nonadherence in patients with uncontrolled hypertension. J Psychosom Res. 2014;77(4):283-286.

[16] Kretchy IA, Owusu-Daaku FT, Danquah SA. Mental health in hypertension: assessing symptoms of anxiety, depression and stress on anti-hypertensive medication adherence. Int J Ment Health Syst. 2014;8:25.

[17] Organization WH. Guideline for the pharmacological treatment of hypertension in adults. https://www.who.int/publications/i/item/9789240033986. Accessed 2023-07-24.

[18] Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67-74.

[19] Abegaz TM, Shehab A, Gebreyohannes EA, Bhagavathula AS, Elnour AA. Nonadherence to antihypertensive drugs: A systematic review and meta-analysis. Medicine (Baltimore). 2017;96(4):e5641.

[20] Marcum ZA, Zheng Y, Perera S, et al. Prevalence and correlates of self-reported medication non-adherence among older adults with coronary heart disease, diabetes mellitus, and/or hypertension. Res Social Adm Pharm. 2013;9(6):817-827.

[21] Alhaddad IA, Hamoui O, Hammoudeh A, Mallat S. Treatment adherence and quality of life in patients on antihypertensive medications in a Middle Eastern population: adherence. Vasc Health Risk Manag. 2016;12:407-413.

[22] Said B, Gharawi MO, Dallak FH, et al. Factors Associated with Anxiety During COVID-19 Pandemic and Its Association with Hypertension in Saudi Arabia. Patient Prefer Adherence. 2023;17:905-912.

[23] Liu Y, Li P, Lv Y, et al. Public awareness and anxiety during COVID-19 epidemic in China: A cross-sectional study. Compr Psychiatry. 2021;107:152235.

[24] Polack FP, Thomas SJ, Kitchin N, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020;383(27):2603-2615.

[25] Jackson LA, Anderson EJ, Rouphael NG, et al. An mRNA Vaccine against SARS-CoV-2 - Preliminary Report. N Engl J Med. 2020;383(20):1920-1931.

[26] Wang G, Yao Y, Wang Y, et al. Determinants of COVID-19 vaccination status and hesitancy among older adults in China. Nat Med. 2023;29(3):623-631.

[27] Zota D, Diamantis DV, Katsas K, et al. Essential Skills for Health Communication, Barriers, Facilitators and the Need for Training: Perceptions of Healthcare Professionals from Seven European Countries. Healthcare (Basel). 2023;11(14).

[28] Fiscella K, Meldrum S, Franks P, et al. Patient trust: is it related to patient-centered behavior of primary care physicians? Med Care. 2004;42(11):1049-1055.

[29] Zolnierek KB, Dimatteo MR. Physician communication and patient adherence to treatment: a meta-analysis. Med Care. 2009;47(8):826-834.

[30] Position statement of the ESC Council on Hypertension on ACE-inhibitors and angiotensin receptor blockers. European Society of Cardiology. https://www.escardio.org/Councils/Council-on-Hypertension-(CHT)/News/position-statement-of-the-esc-council-on-hypertension-on-ace-inhibitors-and-ang. Accessed [2023-05-23].

[31] A statement from the International Society of Hypertension on COVID-19. International Society of Hypertension. https://ish-world.com/a-statement-from-the-international-society-of-hypertension-on-covid-19/. Updated 2020-03-16. Accessed 2023-05-23.

[32] Lawler PR, Derde LPG, van de Veerdonk FL, et al. Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial. Jama. 2023;329(14):1183-1196.